Tang X, Zhang W, Zhang Z
Vaccines (Basel). 2025; 13(2).
PMID: 40006681
PMC: 11861332.
DOI: 10.3390/vaccines13020135.
Rollins K, Fiaz S, Morrissey M
bioRxiv. 2025; .
PMID: 39975079
PMC: 11839035.
DOI: 10.1101/2025.02.06.636906.
Charmetant X, Rigault G, Chen C, Kaminski H, Visentin J, Taton B
Transpl Int. 2025; 38:12859.
PMID: 39944220
PMC: 11815947.
DOI: 10.3389/ti.2025.12859.
Brestoff J, Singh K, Aquilano K, Becker L, Berridge M, Boilard E
Nat Metab. 2025; 7(1):53-67.
PMID: 39820558
DOI: 10.1038/s42255-024-01200-x.
Zhai Y, Liang X, Deng M
Chin J Cancer Res. 2025; 36(6):616-651.
PMID: 39802897
PMC: 11724180.
DOI: 10.21147/j.issn.1000-9604.2024.06.04.
Trogocytosis-mediated immune evasion in the tumor microenvironment.
Kim J, Park S, Kim J, Kim Y, Yoon H, Rayhan B
Exp Mol Med. 2024; 57(1):1-12.
PMID: 39741180
PMC: 11799389.
DOI: 10.1038/s12276-024-01364-2.
CAR T Cell Nanosymbionts: Revealing the Boundless Potential of a New Dyad.
Baena J, Perez L, Toro-Pedroza A, Kitawaki T, Loukanov A
Int J Mol Sci. 2024; 25(23).
PMID: 39684867
PMC: 11642191.
DOI: 10.3390/ijms252313157.
AGC family kinase of Entamoeba histolytica: Decoding the members biochemically.
Ahmad A, Kumar V, Kushwaha T, Kumar A, Sehgal D, Inampudi K
PLoS Pathog. 2024; 20(11):e1012729.
PMID: 39561205
PMC: 11642994.
DOI: 10.1371/journal.ppat.1012729.
Trogocytosis in CAR immune cell therapy: a key mechanism of tumor immune escape.
Chen Y, Xin Q, Zhu M, Qiu J, Qiu J, Li R
Cell Commun Signal. 2024; 22(1):521.
PMID: 39468646
PMC: 11514842.
DOI: 10.1186/s12964-024-01894-2.
Reshaping the tumor microenvironment by degrading glycoimmune checkpoints Siglec-7 and -9.
Wang C, Hou Y, Zak J, Zheng Q, McCord K, Wu M
bioRxiv. 2024; .
PMID: 39416090
PMC: 11483058.
DOI: 10.1101/2024.10.11.617879.
Therapeutic antibodies in oncology: an immunopharmacological overview.
Toledo-Stuardo K, Ribeiro C, Gonzalez-Herrera F, Matthies D, Le Roy M, Dietz-Vargas C
Cancer Immunol Immunother. 2024; 73(12):242.
PMID: 39358613
PMC: 11448508.
DOI: 10.1007/s00262-024-03814-2.
Intercellular Transfer of Immune Regulatory Molecules Via Trogocytosis.
Park S, Kim J, Shin J
Results Probl Cell Differ. 2024; 73:131-146.
PMID: 39242377
DOI: 10.1007/978-3-031-62036-2_6.
The Biological Significance of Trogocytosis.
Agbakwuru D, Wetzel S
Results Probl Cell Differ. 2024; 73:87-129.
PMID: 39242376
PMC: 11784324.
DOI: 10.1007/978-3-031-62036-2_5.
Regulation of the hematopoietic stem cell pool by C-Kit-associated trogocytosis.
Gao X, Carpenter R, Boulais P, Zhang D, Marlein C, Li H
Science. 2024; 385(6709):eadp2065.
PMID: 39116219
PMC: 11533977.
DOI: 10.1126/science.adp2065.
Contemporary Approaches to Immunotherapy of Solid Tumors.
Kuznetsova A, Glukhova X, Popova O, Beletsky I, Ivanov A
Cancers (Basel). 2024; 16(12).
PMID: 38927974
PMC: 11201544.
DOI: 10.3390/cancers16122270.
Chimeric Cell Therapies as a Novel Approach for Duchenne Muscular Dystrophy (DMD) and Muscle Regeneration.
Budzynska K, Siemionow M, Stawarz K, Chambily L, Siemionow K
Biomolecules. 2024; 14(5).
PMID: 38785982
PMC: 11117592.
DOI: 10.3390/biom14050575.
Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy.
Dreyzin A, Rankin A, Luciani K, Gavrilova T, Shah N
Expert Rev Clin Immunol. 2024; 20(7):745-763.
PMID: 38739466
PMC: 11180598.
DOI: 10.1080/1744666X.2024.2349738.
The trogocytosis of neutrophils on initial transplanted tumor in mice.
Zhu M, Wang S, Qu K, Lu F, Kou M, Yao Y
iScience. 2024; 27(5):109661.
PMID: 38650980
PMC: 11033691.
DOI: 10.1016/j.isci.2024.109661.
Receptor transfer between immune cells by autoantibody-enhanced, CD32-driven trogocytosis is hijacked by HIV-1 to infect resting CD4 T cells.
Albanese M, Chen H, Gapp M, Muenchhoff M, Yang H, Peterhoff D
Cell Rep Med. 2024; 5(4):101483.
PMID: 38579727
PMC: 11031382.
DOI: 10.1016/j.xcrm.2024.101483.
Paradoxical imbalance between activated lymphocyte protein synthesis capacity and rapid division rate.
Seedhom M, Dersh D, Holly J, Pavon-Eternod M, Wei J, Angel M
Elife. 2024; 12.
PMID: 38512721
PMC: 10957176.
DOI: 10.7554/eLife.89015.
